Human papillomavirus-related cell cycle markers can predict survival outcomes following a transoral lateral oropharyngectomy for tonsillar squamous cell carcinoma
- 5 June 2014
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 110 (4) , 393-399
Abstract
Objectives To identify the prognostic implications of human papillomavirus (HPV)-related cell cycle marker profiles in patients who have received a transoral lateral oropharyngectomy (TLO) as a primary treatment for tonsillar squamous cell carcinoma (TSCC). Patients and Methods Immunohistochemical profiles of HPV-related cell cycle markers, including p16, pRb, cyclin D1, p53, and the HPV DNA status of 42 consecutive TSCC patients who underwent TLO-based treatments were analyzed. The prognostic value of each marker was evaluated. Results Univariate analysis indicated that high p16, low pRb, and low p53 expression levels are significantly associated with a good disease-free and overall survival outcome. Clinicopathological parameters and the HPV DNA status did not show prognostic significance. When adjusted for age, overall stage and treatment strategy, a high p16 and low pRb level remained an effective prognostic marker for good survival outcomes. A high p16/low pRb combination showed superior survival prediction ability over high p16 or low pRb alone. Conclusion HPV-related cell cycle markers may also be good indicators for predicting survival after TLO for TSCC. The de-escalation TLO surgery approach would be more effective if performed under the stringent guidance of these markers. J. Surg. Oncol. 2014; 110:393–399.Keywords
Funding Information
- National Cancer Center (1210220)
This publication has 24 references indexed in Scilit:
- p16 expression as a surrogate marker for HPV‐related oropharyngeal carcinoma: A guide for interpretative relevance and consistencyHead & Neck, 2011
- Human papillomavirus in oropharyngeal squamous cell carcinomas in korea: Use of G1 cycle markers as new prognosticatorsHead & Neck, 2011
- Human Papillomavirus and Survival of Patients with Oropharyngeal CancerNew England Journal of Medicine, 2010
- High-Risk Human Papillomavirus Affects Prognosis in Patients With Surgically Treated Oropharyngeal Squamous Cell CarcinomaJournal of Clinical Oncology, 2006
- Management of Contralateral N0 Neck in Tonsillar Squamous Cell CarcinomaThe Laryngoscope, 2005
- Detection of HPV genotypes in cervical lesions by the HPV DNA Chip and sequencingGynecologic Oncology, 2005
- Transoral Lateral Oropharyngectomy for Squamous Cell Carcinoma of the Tonsillar RegionJAMA Otolaryngology–Head & Neck Surgery, 2005
- Transoral Lateral Oropharyngectomy for Squamous Cell Carcinoma of the Tonsillar RegionJAMA Otolaryngology–Head & Neck Surgery, 2005
- Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and NeckNew England Journal of Medicine, 2004
- Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck CancerNew England Journal of Medicine, 2004